17th ANNUAL EARLY HEARING DETECTION & INTERVENTION MEETING
March 18-20, 2018 • Denver, CO
| A Retrospective Review of Timely Intervention for Children with Congenital Microtia and Aural Atresia in a Multidisciplinary Clinic
A Retrospective Review of Timely Intervention for Children with Congenital Microtia and Aural Atresia in a Multidisciplinary Clinic
Microtia and aural atresia are birth abnormalities of the ear. A complete diagnostic hearing evaluation is recommended for all children with congenital microtia and aural atresia. Microtia in varying degrees occurs from 0.83 to 17.4 per 10,000 births and occurs unilaterally 79-93%. Children born with unilateral microtia typically have normal hearing sensitivity in the contralateral ear, however, they are at increased risk for delayed speech-language, academic, and social-emotional development. A diagnostic hearing evaluation should be completed soon following birth to determine hearing status for both ears. A review of patients attending the Children’s Hospital Colorado Microtia and Atresia Multidisciplinary Clinic was completed to determine if a diagnostic hearing evaluation and early intervention were initiated according to evidence-based guidelines. A retrospective chart review included approximately 50 children born between 2012-2017. The results of this review will benefit providers involved with newborn hearing screening programs, the medical home, and multidisciplinary teams supporting children with congenital microtia and aural atresia.
- Describe the importance of referring a child with congenital microtia and aural atresia for a diagnostic hearing evaluation following a newborn hearing screening.
- Explain the purpose of referring a child with congenital microtia and aural atresia to a physician specializing in evaluation of ears.
- Identify the components that contribute to timely intervention for children with congenital microtia and aural atresia.
Presentation:
15805_7782KirstenAdkisson.pdf
Handouts:
Handout is not Available
Transcripts:
CART transcripts are NOT YET available, but will be posted shortly after the conference
Presenters/Authors
Kirsten Adkisson
(), Children's Hospital Colorado, kirsten.adkisson@childrenscolorado.org;
Kirsten Adkisson, AuD, joined the Bill Daniels Center for Children’s Hearing at Children’s Hospital Colorado as an Audiologist in 2010. Kirsten completed her Bachelor of Arts in Communication Disorders: Audiology and Speech-Language Pathology at the University of Northern Colorado. She continued at the University of Northern Colorado to complete her Doctor of Audiology degree in 2009. She has more than seven years of experience as an audiologist specializing in pediatric diagnostic evaluations and management. Her clinical interests include bone conduction hearing devices (BCHD) and management of children with hearing loss using BCHD. Kirsten joined the Children’s Hospital Colorado Microtia and Atresia Clinic in 2017. She is also active in audiology student supervision and mentoring and is credentialed as a Certificate Holder-Audiology Preceptor (CH-AP) through the American Board of Audiology.
ASHA DISCLOSURE:
Financial -
Receives Salary for Employment from Children's Hospital Colorado.
Receives Salary for Employment from Children's Hospital Colorado.
Nonfinancial -
No relevant nonfinancial relationship exist.
Megan Hedman
(), Children's Hospital Colorado, megan.hedman@childrenscolorado.org;
Megan Hedman, AuD, joined the Bill Daniels Center for Children’s Hearing (BDCCH) at Children’s Hospital Colorado as an Audiologist in 2013 after completing her fourth year externship at the BDCCH. Megan completed her Bachelor of Arts in Speech Language and Hearing Sciences with a minor in Political Science and certificate in Leadership Theory and Practice at the University of Colorado, Boulder. She continued at the University of Colorado, Boulder to complete her Doctor of Audiology in 2013. She has been a member of the Microtia Clinic as a family consultant since May 2007, as she has right-sided microtia and atresia herself. Because of her own hearing loss and congenital anomaly, she has taken much interest in pediatric audiology specializing in early intervention, educational access, self-advocacy and Bone Conduction Hearing Devices (BCHD). In addition to her clinical interests, Megan participates in research related to Visual Reinforcement Infant Speech Discrimination (VRISD), volunteers as a Role Model through the Colorado School for the Deaf and Blind, serves as the Vice President of Membership for the Colorado Academy of Audiology and participates on a Unilateral Hearing Loss Advisory Council through Colorado Hands & Voices.
ASHA DISCLOSURE:
Financial -
No relevant financial relationship exist.
Nonfinancial -
No relevant nonfinancial relationship exist.